|
Market Closed -
NYSE
06:04:05 12/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 101.95 USD | -1.36% |
|
-5.89% | -18.63% |
| 08/09 | Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm | DJ |
| 08/09 | Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms | CI |
Chart calendar Abbott Laboratories
Upcoming events on Abbott Laboratories
No events available
Past events on Abbott Laboratories
| 16/07/2026 | Earnings presentation | 11:00 pm |
| 16/07/2026 | Earnings release - Q2 2026 | |
| 24/04/2026 | Présentation aux Actionnaires / Analystes | 11:00 pm |
| 24/04/2026 | Annual General Meeting | 11:00 pm |
| 16/04/2026 | Earnings release - Q1 2026 | |
| 16/04/2026 | Earnings presentation | 11:00 pm |
| 23/01/2026 | Earnings release - Q4 2025 | |
| 23/01/2026 | Earnings presentation | 01:00 am |
| 16/10/2025 | Earnings presentation | 12:00 am |
| 16/10/2025 | Earnings release - Q3 2025 |
Past dividends on Abbott Laboratories
| 15/07/2026 | Ex-dividend date - 0.63 USD | 02:00 pm |
| 15/04/2026 | Ex-dividend date - 0.63 USD | 02:00 pm |
| 15/01/2026 | Ex-dividend date - 0.63 USD | 04:00 pm |
| 15/10/2025 | Ex-dividend date - 0.59 USD | 03:00 pm |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 40 109 40 077 0.08% | 41 950 41 988 -0.09% | 44 328 44 675 -0.78% | 50 204 | 54 528 | 58 247 |
|
EBITDA Million USD | Released Forecast Spread | 10 188 10 191 -0.03% | 10 635 10 653 -0.17% | 11 735 11 873 -1.17% | 12 989 | 14 491 | 15 854 |
|
EBIT Million USD | Released Forecast Spread | 8 911 8 883 0.32% | 9 295 9 341 -0.49% | 10 301 10 372 -0.69% | 11 719 | 13 021 | 14 319 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 664 6 563 1.54% | 7 013 7 271 -3.55% | 8 466 8 669 -2.35% | 7 434 | 9 708 | 11 330 |
|
Net income Million USD | Released Forecast Spread | 5 723 5 652 1.26% | 13 402 5 934 125.87% | 6 524 6 923 -5.77% | 6 303 | 7 978 | 8 906 |
|
EPS USD | Released Forecast Spread | 3,26 3,23 0.81% | 7,64 3,42 123.37% | 3,72 3,98 -6.46% | 3,53 | 4,55 | 5,11 |
| Announcement Date | 24/01/24 | 22/01/25 | 22/01/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 10 974 11 031 -0.52% | 10 358 10 417 -0.57% | 11 142 11 058 0.76% | 11 369 11 393 -0.21% | 11 459 11 802 -2.91% | 11 164 10 998 1.51% | 12 593 12 517 0.61% | 12 992 | 13 542 | 12 787 | 13 499 | 13 914 | 14 477 | 13 685 | 14 495 |
|
EBITDA Million USD | Released Forecast Spread | 3 006 3 069 -2.04% | 2 514 2 474 1.63% | 2 908 2 842 2.34% | 2 981 3 035 -1.78% | 3 332 3 423 -2.67% | 2 655 2 648 0.26% | 3 245 3 275 -0.93% | 3 450 | 3 900 | 3 103 | 3 529 | 3 794 | 4 118 | 3 701 | 3 971 |
|
EBIT Million USD | Released Forecast Spread | 2 664 2 710 -1.7% | 2 178 2 161 0.78% | 2 551 2 551 -0% | 2 610 2 642 -1.2% | 2 962 3 037 -2.46% | 2 274 2 268 0.28% | 2 843 2 795 1.72% | 3 075 | 3 528 | 2 755 | 3 129 | 3 375 | 3 758 | 3 187 | 3 457 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 030 2 082 -2.47% | 1 778 1 643 8.25% | 2 150 2 150 0% | 2 180 2 155 1.14% | 2 358 2 406 -2% | 1 449 1 852 -21.75% | 1 524 1 866 -18.33% | 2 008 | 2 400 | 1 857 | 2 173 | 2 496 | 2 786 | 2 231 | 2 498 |
|
Net income Million USD | Released Forecast Spread | 9 229 1 807 410.6% | 1 325 1 359 -2.49% | 1 779 1 762 0.98% | 1 644 1 828 -10.08% | 1 776 2 104 -15.59% | 1 077 1 510 -28.66% | 928 1 608 -42.29% | 1 764 | 2 126 | 1 587 | 1 923 | 2 086 | 2 390 | 2 070 | 2 180 |
|
EPS USD | Released Forecast Spread | 5,27 1,05 404.2% | 0,76 0,78 -2.59% | 1,01 0,99 1.86% | 0,94 1,04 -9.72% | 1,01 1,21 -16.48% | 0,61 0,87 -29.77% | 0,53 0,95 -44.16% | 1,01 | 1,22 | 0,90 | 1,09 | 1,24 | 1,42 | 1,19 | 1,25 |
| Announcement Date | 22/01/25 | 16/04/25 | 17/07/25 | 15/10/25 | 22/01/26 | 16/04/26 | 16/07/26 | - | - | - | - | - | - | - | - |
| 14/09/2026 |  | Earnings presentation | 11:00 am |
| 14/09/2026 | | Earnings presentation | 05:00 pm |
| 15/09/2026 | | Extraordinary General Meeting | 04:00 pm |
| 15/09/2026 | | Earnings presentation | 05:30 pm |
| 15/09/2026 | | Earnings presentation | 12:00 pm |
| 17/09/2026 | | Analyst/Investor Day | 11:00 pm |
| 17/09/2026 | | Earnings presentation | 05:00 pm |
| 17/09/2026 | | Earnings presentation | 05:00 pm |
| 17/09/2026 | | Extraordinary General Meeting | 04:30 pm |
| 18/09/2026 | | Extraordinary General Meeting | 05:00 pm |
Past sector events for Abbott Laboratories
| 10/09/2026 | | Extraordinary General Meeting | 04:30 pm |
| 09/09/2026 | | Ex-dividend date - 1.05 USD | 02:00 pm |
| 09/09/2026 | | Extraordinary General Meeting | 04:30 pm |
| 09/09/2026 | | Earnings release - Q2 2026 | |
| 09/09/2026 | | Earnings presentation | 11:00 pm |
| 09/09/2026 | | Annual General Meeting | 04:00 am |
| 09/09/2026 | | Extraordinary General Meeting | 04:30 pm |
| 05/09/2026 | | Annual General Meeting | 03:30 pm |
| 05/09/2026 | | Présentation aux Actionnaires / Analystes | 03:30 pm |
| 04/09/2026 | | Ex-dividend date - 0.69 USD | 02:00 pm |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- Calendar Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions
